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Objective: To assess the effect of isocaloric isonitrogenous paren-
teral glutamine supplementation on intestinal permeability and ni-
trogen loss in newborns and infants after major digestive-tract
surgery.
Summary Background Data: Glutamine supplementation in criti-
cally ill and surgical adults may normalize intestinal permeability,
attenuate nitrogen loss, improve survival, and lower the incidence of
nosocomial infections. Previous studies in critically ill children were
limited to very-low-birthweight infants and had equivocal results.
Methods: Eighty newborns and infants were included in a double-
blind, randomized trial comparing standard parenteral nutrition
(sPN; n  39) to glutamine-supplemented parenteral nutrition
(GlnPN; glutamine target intake, 0.4 g kg1 day1; n 41), starting
on day 2 after major digestive-tract surgery. Primary endpoints were
intestinal permeability, as assessed by the urinary excretion ratio of
lactulose and rhamnose (weeks 1 through 4); nitrogen balance (days
4 through 6), and urinary 3-methylhistidine excretion (day 5).
Secondary endpoints were mortality, length of stay in the ICU and
the hospital, number of septic episodes, and usage of antibiotics and
ICU resources.
Results: Glutamine intake plateaued at 90% of the target on day 4.
No differences were found between patients assigned sPN and
patients assigned GlnPN regarding any of the endpoints. Glutamine
supplementation was not associated with adverse effects.
Conclusions: In newborns and infants after major digestive-tract
surgery, we did not identify beneficial effects of isonitrogenous,
isocaloric glutamine supplementation of parenteral nutrition. Glu-
tamine supplementation in these patients therefore is not warranted
until further research proves otherwise.
(Ann Surg 2005;241: 599–606)
Glutamine is the most abundant free amino acid of thebody and has many essential metabolic functions. Dur-
ing critical illness, demands are increased and may not be met
by endogenous supply and dietary intake.1 In critically ill
adults, placebo-controlled randomized studies have shown
that glutamine supplementation normalizes intestinal perme-
ability, attenuates nitrogen losses, and enhances immunologic
defenses against infection.1–7 Related clinical effects include
improved survival, a lower incidence of infections, shorter
hospital stay, and lower ICU and hospital costs.1,3,5,8,9 Pla-
cebo-controlled randomized studies in critically ill children
have so far been limited to very-low-birthweight infants.10–13
Lacey et al10 studied 78 preterm infants and concluded that
parenteral glutamine reduced the time on total parenteral
nutrition (PN) and on the mechanical ventilator and acceler-
ated the transition to full enteral feeding in a subgroup of
infants weighing less than 800 g. Neu et al11 studied 67
very-low-birthweight infants and concluded that enteral glu-
tamine lowered the incidence of sepsis, improved the tolerance
to enteral feeding, and lowered hospital costs.14 A subsequent
multicenter trial in 649 very-low-birthweight infants, however,
failed to show an effect of enteral glutamine on the incidence of
blood-culture-proven nosocomial sepsis.13
We hypothesized that glutamine supplementation
might be of benefit to newborns and infants who needed
intensive care and PN after major digestive-tract surgery. The
From the *Departments of Pediatric Surgery, †Public Health, ‡Internal
Medicine, and §Clinical Genetics, Sophia Children’s Hospital/Erasmus
Medical Center, Rotterdam, The Netherlands.
Reprints: M. J. I. J. Albers, Department of Pediatrics, Groningen University
Hospital, X4.127, PO Box 30001, 9700 RC Groningen, The Netherlands.
E-mail: m.albers@bkk.azg.nl.
Copyright © 2005 by Lippincott Williams & Wilkins
ISSN: 0003-4932/05/24104-0599
DOI: 10.1097/01.sla.0000157270.24991.71
Annals of Surgery • Volume 241, Number 4, April 2005 599
primary endpoints of this study were the effect of isocaloric
isonitrogenous parenteral glutamine supplementation on in-
testinal permeability and nitrogen loss in this population.
MATERIALS AND METHODS
Study Outline
The study protocol was approved by the institutional
review board. The study was designed as a double-blind
randomized controlled trial. In newborns and infants who
needed intensive care after digestive-tract surgery, we com-
pared standard PN (sPN) with isonitrogenous, isocaloric,
glutamine-supplemented PN (GlnPN). The primary endpoints
of the study were intestinal permeability, as measured by
sugar absorption tests; nitrogen balance; and urinary 3-meth-
ylhistidine (3MH) excretion. Secondary endpoints were mor-
tality and morbidity. Measures of morbidity assessed were
length of ICU stay and length of hospital stay; number of
septic episodes; usage of antibiotics; usage of ICU resources,
as assessed by the therapeutic intervention scoring system 76
(TISS); and renal and hepatic damage, as assessed by renal
and liver function tests.
Patients
Our pediatric surgical ICU is part of a tertiary referral
university children’s hospital. Provided informed parental
consent was obtained, patients admitted to our ICU were
enrolled if they fulfilled all of the inclusion criteria and none
of the exclusion criteria. The inclusion criteria were gesta-
tional age 30 weeks and age 2 years and not expected to
tolerate enteral nutrition for at least 4 days following diges-
tive-tract surgery. Exclusion criteria were simultaneous par-
ticipation in another trial or previous participation in the
current trial, preexistent renal or hepatic dysfunction that
precluded the use of sPN, an inborn error of metabolism, an
immunodeficiency or a disease that entailed impaired growth
(other than dysmaturity), the use of corticosteroid drugs,
preexistent life expectancy less than 6 months.
Baseline data included demographic data, index diag-
nosis, operative procedure, and the Pediatric Risk of Mortal-
ity II score (PRISM) and Surgical Stress Score (SSS).
PRISM, obtained on the day of admission to the ICU, was
used to assess the severity of illness;15 SSS, to assess the
severity of the postoperative stress response.16
Stratification, Randomization, Blinding
The patients were divided into 4 strata according to age:
I, gestational age 30 weeks and postconceptional age 37
weeks; II, postconceptional age 37 weeks and age 0.5
year; III, age 0.5 and 1 year; IV, age 1 and 2 years.
We used a computer-generated randomization schedule to
assign patients sPN or GlnPN. Patients were randomized
blockwise in groups of 4. The randomization schedule was
made available only to the pharmacist that supervised the
processing of PN. Glutamine-enriched and standard nutrition
bags were labeled identically. All physicians and nurses
involved in the patients’ care were blinded to nutrition as-
signments.
PN
On a daily basis, PN was custom made for each patient.
A 2-bag system was used, with one bag containing amino
acids (Vaminolact; Pharmacia, Stockholm, Sweden), carbo-
hydrates (dextrose; Fresenius, Bad Homburg, Germany),
minerals, trace elements, carnitene, water-soluble vitamins,
and water, and the other bag containing lipids (Intralipid
20%; Pharmacia) and fat-soluble vitamins. Total PN was
started on day 2 after surgery (designated day 0), according to
hospital guidelines, stating that amino acid and lipid intake
start at approximately 50% of the recommended intake in the
first 24 hours of parenteral feeding and reach the recom-
mended intake in the following 24 hours. Depending on
weight, recommended intakes were 1.5 to 2.5 g/kg/24 hours
of amino acids and 85 to 100 kcal/kg/24 hours, with carbo-
hydrates providing approximately 65% of nonprotein calories
and fat approximately 35%. Provided the patient’s condition
and the surgical procedure would allow it, tapering of PN and
reintroduction of enteral nutrition was started on or after day
6. PN was withheld once patients received more than 75% to
80% of the recommended intake via the enteral route. If
patients needed to revert to parenteral feeding, they were
assigned the same PN (sPN or GlnPN) as before. If patients
were still being fed parenterally at day 31, the study nutrition
would be replaced by sPN.
L-Glutamine was purchased as a 2.5% solution in
sterile water from Oxford Nutrition (Oxford, UK) and stored
at 20°C. Isonitrogenous isocaloric supplementation was
achieved by substituting predefined volumes of amino acids
and water with L-glutamine. Based on a study by Allen et
al,17 we aimed to administer 0.4 g of glutamine per kilogram
body weight per day to patients fully dependent on PN.
Parenteral glutamine intake and nonprotein caloric intake
were calculated in the same fashion as nitrogen intake (see
below).
Sugar Absorption Tests
A sugar absorption test was performed on the fifth day
of the first through fourth week after surgery, unless the
patient had already been discharged from the hospital. The
test solution was prepared by the hospital pharmacy. One
hundred forty milligrams of glucose, 140 mg of rhamnose,
and 70 mg of xylose were dissolved in 50 mL demineralized
water, 8.6 g of lactulose was added, and demineralized water
was added up to a total volume of 100 mL. Patients were
given 1 mL of this solution per kilogram body weight, via
nasogastric tube. Urine passed in the next 4 hours was
collected; if the collection failed, the test was repeated once
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within the next 24 hours. One milliliter was frozen at 80°C
until thawing and analysis. We have described the details of
the analytical procedure elsewhere.18 The sugars’ urinary
excretions were expressed as a percentage of the dose in-
gested and the lactulose-rhamnose ratio as the ratio of these
percentages.
Nitrogen Balance
Nitrogen balance data were acquired on days 4, 5, and
6. The nitrogen-excretion data were also used to study the
contribution of nonurinary nitrogen loss to total nitrogen loss
and have recently been published.19 All excreta, with the
exception of bronchopulmonary secretions and 1 patient’s
decubitus wound exudate, were collected, stored, and ana-
lyzed.19 Nitrogen intake was calculated as the product of the
volumes and the nitrogen contents of the administered amino
acid solutions. The nitrogen content was calculated for each
solution separately, based on the product information and the
patients’ PN datasheets. Nitrogen balance was calculated as
the difference between nitrogen intake and nitrogen excretion
and expressed as milligrams nitrogen per kilogram body
weight per 24 hours.
Urinary 3MH Excretion
An aliquot of the urine collected on day 5 was used to
calculate 3MH excretion. Urinary 3MH content was mea-
sured by ion exchange chromatography on a Biochrome 20
amino acid analyser with ninhydrin detection (Biochrome,
Cambridge, UK). Twenty-four-hour urinary 3MH excretion
was calculated in the same fashion as 24-hour urinary nitro-
gen excretion19 and expressed as micromoles per kilogram
body weight per day. The urinary 3MH-creatinine ratio was
expressed as micromoles per millimole.
Mortality, Length of Stay in the ICU and in the
Hospital
A distinction was made between 31-day mortality (ie,
mortality during the interval that the study nutrition was used
as PN) and all-cause in-hospital mortality. Length of stay in
the ICU and in the hospital was expressed in days and
calculated as the difference between the date of discharge and
the start of surgery.
Septic Episodes, Antibiotic Usage
The Centers for Disease Control and Prevention criteria
for nosocomial infections were used to identify septic
events.20 For septic events to be taken into account, positive
blood cultures were mandatory. Primary and secondary
bloodstream infections were grouped together as “sepsis.”
Standard 48-hour perioperative antibiotic prophylaxis con-
sisted of amoxicillin and cefotaxime or cefoxitin and tobramy-
cin, depending on age. Conversion to a therapeutic regimen was
based on the underlying disease and the intraoperative find-
ings. Empirical therapy for nosocomial infections was di-
rected by hospital guidelines. During the study period, the
antibiotic policy did not change. As part of standard patient
care, medication prescription data were entered into the
hospital information system by the hospital pharmacy. We
retrieved these data to calculate the number of antibiotic
doses prescribed to each trial patient on each day, from day 0
through day 31.
TISS
As part of standard ICU patient care, TISS data were
prospectively entered into the hospital information system by
the ICU nurses during each night shift.21 We retrieved the
TISS data for each patient from day 0 through day 31. A TISS
score of 0 was assigned each day a patient was not in the ICU.
As a result of a problem with electronic storage of TISS data
in the hospital information system, not all TISS data were
retrievable. We did not attempt to reconstruct missing data
but analyzed the data that were available.
Renal and Liver Function Tests
Serum urea and creatinine were determined on days 4
through 6 and on day 7 of the second through fourth week
after surgery; total and direct bilirubin, aspartate and alanine
aminotransferases, -glutamyltransferase, alkaline phospha-
tase, lactate dehydrogenase, and ammonia were determined
on day 7 of the first through fourth week. Blood samples were
not taken if the patient did not receive any PN.
Statistical Analyses
Normal lactulose-rhamnose ratios in newborns and in-
fants are approximately 0.05  0.02 (mean  1 SD).22 With
2-sided tests,   0.05 and   0.20, we calculated that
inclusion of 80 patients should allow us to detect a between-
group difference of 0.015. At the time the study was planned,
nitrogen balance and 3MH excretion data were not available
for similar populations of surgical infants. Power calculations
were therefore restricted to lactulose-rhamnose ratios.
Analyses were by intention-to-treat. Differences in de-
velopment over time in the 2 treatment groups were analyzed
with repeated-measures analysis of variance (analysis of
variance proc mixed; v8.2, SAS Institute Inc, Cary, NC). We
used random-intercept models that allowed inclusion of all
available data. The models comprised main effects of treat-
ment and time and the interaction between treatment and
time. Time was included as a factor with a number of levels
equal to the maximum number of measurements available per
subject to account for possible nonlinearities over time. Sugar
absorption data were log-transformed before analysis because
of a skewed distribution. All other analyses were performed
with StatView (v4.5; SAS Institute Inc). In view of the
relatively small patient numbers, we did not perform sub-
group analyses. A P value 0.05 was considered statistically
significant.
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RESULTS
From January 1, 1997, through December 31, 1999,
108 newborns and infants fulfilled the inclusion criteria (Fig.
1). Three patients were excluded because they had partici-
pated in the trial before. In 25 patients, parental consent was
not obtained. Of the 80 patients randomized, 39 were as-
signed sPN and 41 were assigned GlnPN. One of the patients
assigned sPN was withdrawn from the study on day 3 when
it became obvious that enteral feeding would be tolerated.
Baseline data are summarized in Table 1 and Table 2.
Demographic data, PRISM, SSS, and nitrogen and caloric
intake in the first week after surgery of patients receiving sPN
and of those receiving GlnPN were similar (Table 1, Fig. 2).
Glutamine intake reached a plateau of well over 90% of the
target (0.4 g kg1 day1) on day 4 (Fig. 2). In univariate
correlation analyses, we found no relation between PRISM or
SSS and glutamine intake. Caloric intake also reached a
plateau on day 4 of approximately 80% of the target (Fig. 2).
Primary Endpoints
In patients assigned sPN, 81 of 111 planned tests
succeeded (73%), and in patients assigned GlnPN, 100 of 126
tests succeeded (79%; Fig. 1). Repeated-measures analysis
showed that the urinary excretion ratio of lactulose and
rhamnose (Table 3) and the excretion of any of the 4 sugars
tested (data not shown) did not differ between study groups at
any time after surgery.
Nitrogen excretion data were acquired in 37 patients
assigned sPN and in 40 patients assigned GlnPN (Fig. 1).
Overall, 76 valid collections of excreta were obtained on day
4, 68 on day 5, and 68 on day 6. Repeated-measures analysis
of variance did not show significant differences between the
nitrogen balance data of sPN and GlnPN patients (Table 3).
3MH-creatinine excretion ratios were obtained in 34
sPN patients and 36 GlnPN patients. In 1 sPN patient, urine
volume was not measured reliably, so that 24-hour 3MH
excretion was determined only in 33 sPN patients (Fig. 1).
Twenty-four-hour 3MH excretion was higher in sPN patients
than in GlnPN patients, but the difference was not statistically
significant (Table 3). The 3MH-creatinine ratios did not differ
significantly (Table 3).
In univariate analyses, both PRISM and SSS exerted a
statistically significant but small influence on nitrogen excre-
tion and nitrogen balance (P  0.01; r2  0.09 for all
analyses), but not on nitrogen intake and the 3MH-creatinine
excretion ratio. We also found a statistically significant in-
verse correlation between nitrogen balance and the 3MH-
creatinine ratio (P  0.015; r2  0.084).
Secondary Endpoints
We found a similar 31-day mortality rate, length of stay
in the ICU, and length of stay in the hospital in the 2 groups
(Table 4). Two patients in the GlnPN group died after the first
month (ie, after the period of study nutrition).
FIGURE 1. Flow chart including primary endpoints. PN, par-
enteral nutrition; 3-MH, 3-methylhistidine.
TABLE 1. Baseline Data
Parenteral Nutrition Standard Glutamine-Enriched
Patients (male:female) 39 (27:12) 41 (25:16)
Stratum
I, gestational age 30 wk
and postconceptional age
37 wk
13 12
II, postconceptional age
37 wk and age 0.5 y
22 22
III, age 0.5 y and  1 y 2 4
IV, age 1 y and  2 y 2 3
Weight in kg, median (IQR) 3.0 (2.1–3.8) 2.8 (2.1–3.6)
Age in days, median (IQR) 14 (2.3–54) 8 (2.8–94)
PRISM, median (IQR) 11 (7–17) 9 (6–16)
SSS, median (IQR) 11 (9–13) 11 (9–13)
IQR indicates interquartile range; PRISM, Pediatric Risk of Mortality;
SSS, Surgical Stress Score.
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In 38 sPN patients, 6 culture-proven septic episodes
were identified from days 1 through 31 after surgery and 9 in
41 GlnPN patients (P  0.53; Table 4). The number of
antibiotic dosages prescribed was very similar in the 2 groups
(Table 4). Cumulative TISS scores were retrieved in 32
patients assigned sPN and in 37 patients assigned GlnPN.
Cumulative TISS scores did not differ between groups (Table
4; Fig. 3). Repeated-measures analysis of variance also did
TABLE 2. Primary Diagnoses and Operative Procedures (Standard Parenteral Nutrition: Glutamine-
Supplemented Parenteral Nutrition)
Diagnosis Operative Procedure n
Congenital anomaly (n  50)
Duodenal obstruction Side-to-side anastomosis and/or web resection 6:8
Gastroschisis Primary repair, abdominoplasty 5:2
Small-bowel atresia Resection and reanastomosis or enterostomy 1:6
Hirschsprung disease Colon resection  enterostomy (0:1) 4:3
Rehbein procedure (4:2)
Esophageal atresia Primary anastomosis (0:2) 1:4
Colon interposition (1:2)
Meconium peritonitis Peritoneal lavage and resection 3:0
Gastric outlet obstruction Primary repair 0:2
Functional small-bowel obstruction Resection of afunctional segments full-thickness biopsies 2:0
Anorectal malformation Enterostomy (closure) 2:0
Midgut volvulus Resection and reanastomosis 0:1
Acquired anomaly (n  30)
Necrotizing enterocolitis Resection and enterostomy (5:7) 7:12
Reanastomosis/enterostomy closure (2:5)
Isolated small-bowel perforation Primary repair 3:1
Small-bowel strangulation Resection and reanastomosis 3:0
Intussusception Resection 1:2
Pancreas pseudocyst Marsupialization 1:0
FIGURE 2. Intake of nitrogen (left panel) and nonprotein calories (right panel) on days 2 to 6 after surgery, as a percentage of the
target (mean  SEM). Open circles, patients assigned sPN; closed circles, patients assigned GlnPN. Note that in patients assigned
GlnPN, nitrogen intake values equal glutamine intake values.
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not show significant differences of the TISS scores between
groups. With the exception of ammonia, laboratory tests did
not reveal any differences between the 2 groups at any point
in time (data not shown). Repeated-measures analysis of
ammonia data showed a small but statistically significant
difference between patients assigned sPN and those assigned
GlnPN (overall median 34 versus 44 mol/L; Table 4), and
between points in time (data not shown).
DISCUSSION
In a population of newborns and infants receiving PN
after major digestive-tract surgery, isonitrogenous isocaloric
glutamine supplementation of PN did not affect intestinal
permeability or nitrogen balance. Mortality, length of ICU
and hospital stay, and usage of antibiotics and ICU resources
also were not affected. We did not identify adverse effects of
parenteral glutamine supplementation.
A recent systematic review of glutamine supplementa-
tion in critically ill and surgical adults concluded that the
greatest benefit was to be expected from parenteral adminis-
tration in doses higher than 0.20 g kg1 day1.1 Whether
children might benefit from glutamine has not been estab-
lished.12,13,23 We planned to administer a parenteral glu-
tamine dose of 0.4 g kg1 day1, the highest dose tried in
critically ill infants.12,13 Further increasing the dose would
have implied further lowering the amount of essential and
other amino acids provided. Within 2 days after starting PN,
we realized an average glutamine intake of 0.36 g kg1
day1. Realized intake did not depend on the severity of the
surgical stress or of the underlying disease. Nitrogen intake
TABLE 3. Primary Endpoints
sPN (n  38) GlnPN (n  41) P Value
Lactulose-rhamnose ratio (%/%), median (IQR) 0.11*
Day 5 0.142 (0.044–0.228) 0.093 (0.024–0.150)
Day 12 0.096 (0.067–0.160) 0.087 (0.050–0.239)
Day 19 0.083 (0.022–0.106) 0.080 (0.057–0.137)
Day 26 0.069 (0.025–0.139) 0.071 (0.041–0.104)
Nitrogen balance (mg/kg/24 h), median (IQR) 0.89*
Day 4 150 (63–197) 141 (61–207)
Day 5 154 (61–198) 160 (87–204)
Day 6 136 (72–264) 164 (63–205)
3-Methylhistidine excretion (mol/kg/24 h), median (IQR) 4.0 (2.7–4.7) 3.2 (2.9–3.8) 0.08†
3-Methylhistidine–creatinine ratio (mol/mmol), median (IQR) 47 (36–65) 44 (37–56) 0.42†
IQR indicates interquartile range.
*Repeated-measures analysis of variance.
† Mann-Whitney U statistic.
TABLE 4. Secondary Endpoints
sPN (n  38) GlnPN (n  41) P Value
Deaths (n)
Days 0–31 0 0 —
All cause in-hospital 0 2 0.16*
Length of stay in the ICU (days), median (IQR) 9.5 (4.5–23) 8.0 (4–20) 0.57†
Length of stay in the hospital (days), median (IQR) 31.5 (14–64) 32 (16.8–44.8) 0.80†
Septic episodes, days 0–31 (n) 6 9 0.53*
Cumulative antibiotic dosages, days 0–31, median (IQR) 30 (20–58) 35 (16–62) 0.75†
Cumulative TISS, days 0–31, median (IQR) 119 (44–222) 93 (64–218) 0.82†
Serum ammonia (moL/L), median(IQR) 34 (28–50) 44 (35–59) 0.008‡
IQR indicates interquartile range.
*2 test.
†Mann-Whitney U statistic.
‡Repeated measures analysis of variance, group comparison.
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also plateaued at approximately 90% of the target, which is
lower than the recommended daily allowance for low-birth-
weight infants, but allowed nitrogen retention to approach intra-
uterine rates.24,25 Caloric intake plateaued at approximately 80%
of the target and thus equaled or exceeded the expected total
energy expenditure.26,27 Whereas daily intakes should have
allowed glutamine supplementation to have an effect, cumula-
tive intake may have been too low, as studies in adults suggest
that glutamine may exert its effects only after a minimum of 5 to
6 days of supplementation.1,28 In the present study, tapering of
PN, and therefore of glutamine intake, was allowed to start on
day 6 (ie, 2 days after a satisfactory glutamine intake had been
reached). Thus, the isonitrogenous design of this study—and of
most other studies—may obscure potential benefits of glutamine
supplementation by limiting the intake of glutamine and of
essential and other amino acids.29
The choice of which patients to feed parenterally and
how to taper parenteral feeding is closely linked to the type of
surgical procedure and based on clinical judgment. We real-
ize that the potential effects of glutamine supplementation
may be obscured by loose criteria for PN and that PN should
be used cautiously in ICU patients.30 In particular, some
might prefer transanastomotic tube feeding for patients with
a congenital foregut anomaly. This, however, is not standard
practice, and we were not willing to accept the risks of
transanastomotic feeding. SSS in most patients was higher
than 8, indicating “major surgery.”27 PRISM was high in
comparison with values observed in surgical patients in a
Dutch PRISM validation study.31 Still, our patients consti-
tuted a heterogeneous population (cf. Table 2).
In adults, increased intestinal permeability has been
observed in association with sepsis and organ dysfunction
and after 2 weeks of standard but not glutamine-supple-
mented PN.1,4,32 In newborns older than 2 days, normal
intestinal permeability is not related to gestational age or birth
weight.33 We have previously reported increased intestinal
permeability in critically ill preterm infants operated because
of necrotizing enterocolitis.18 Permeability normalized in
several of these infants, even though total PN was continued
for 3 weeks.18 In newborns on extracorporeal membrane
oxygenation, we found intestinal permeability to be in-
creased, irrespective of whether they received parenteral or
enteral nutrition.34 In the present study, lactulose-rhamnose
ratios remained elevated for up to 4 weeks in the majority of
patients. Also, intestinal permeability in patients who re-
ceived total PN was not statistically different from that in
patients who received enteral nutrition (data not shown).
These findings suggest that not PN per se but rather the
underlying disease, alone or in combination with surgery,
causes increased intestinal permeability.
Resting energy expenditure and (nor)epinephrine levels
in newborn patients increase in response to the stress of
surgery but normalize again within 24 hours.27,35 Preterm
infants may retain nitrogen in the first 72 hours after sur-
gery.36 In the present study, the severity of the surgical stress
and the underlying disease had limited effects on nitrogen
excretion and nitrogen balance, and most patients retained
adequate amounts of nitrogen on days 4 to 6.24 These findings
add to the evidence that the stress response in young infants
may be short-lived. Nevertheless, the urinary 3MH-creatinine
ratio and 3MH excretion were increased, suggesting in-
creased breakdown of muscle protein.37 Increased breakdown
of muscle protein in the face of nitrogen retention may indicate
rerouting of nitrogen fluxes for wound healing or for the defense
against infection.38 Alternatively, persistently increased break-
down of muscle protein might be accompanied by increased
synthesis and thus reflect increased turnover.
In adults with the systemic inflammatory response
syndrome, but not in very-low-birthweight infants, enteral
glutamine supplementation reduced the number of nosoco-
mial infections.9,13 In our population, parenteral glutamine
supplementation did not change the incidence of culture-
proven sepsis, nor did it affect the incidence or severity of
any bacterial infection, as judged by antibiotic usage and
cumulative TISS scores. It should, however, be noted that
TISS does not assess resource usage outside the ICU.
Studies in critically ill adults and children suggest that
glutamine supplementation is safe.1,10,11,13,39–41 Glutamine is
unlikely to have played a role in the 2 in-hospital deaths that
occurred after the study nutrition had been replaced by sPN.
It should be noted that our study did not have sufficient power
to detect differences in mortality, which generally is very low
in pediatric surgical intensive care populations.31 Serum am-
monia was higher in glutamine-supplemented infants, but the
difference was not clinically relevant (Table 4).
FIGURE 3. Cumulative TISS (mean  SEM) from days 0
through 31 after surgery. Open circles, patients assigned sPN;
closed circles, patients assigned GlnPN. Note that patients
discharged from the ICU have a daily TISS of zero.
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In view of the promising results in adults, more re-
search into the effects of glutamine supplementation in in-
fants and children seems justified.23,29 Currently however,
our findings suggest that parenteral glutamine supplementa-
tion for surgical infants is not warranted.
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